Skip to search formSkip to main contentSkip to account menu

Vasomax

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Phentolamine Mesylate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
AB52. What’s new in treatment of female sexual dysfunction?
For recent a decade, field of female sexual dysfunction for classification, it’s pathophysiology and treatment has been focused… 
2005
2005
Tadalafil (cialisTM) - nový inhibitor PDE-5 v léčbě erektilní dysfunkce
10 www.solen.cz Interní medicína pro praxi 2003 / 1 11 www.solen.cz Blokáda fosfodiesterázy v kavernózní svalovině penisu byla k… 
2004
2004
Phentolamine bioequivalence study.
OBJECTIVE To assess the bioequivalence of 2 tablet formulations of phentolamine (Regitine phentolamine 40 mg tablet formulation… 
2002
2002
Long-term safety and efficacy of oral phentolamine mesylate (Vasomax®) in men with mild to moderate erectile dysfunction
The objectives of this study were to evaluate long-term safety and efficacy of phentolamine mesylate, an orally active, rapid… 
Review
2001
Review
2001
Aviptadil (Senatek).
Aviptadil is an injectable formulation of vasoactive intestinal polypeptide (VIP) in combination with the adrenergic drug… 
2000
2000
Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
Phentolamine mesylate is an alpha-1 and alpha-2 selective adrenergic receptor antagonist which has undergone clinical trials for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)